John Patrick Shannon Jr., Chief Commercial Officer at Durata Therapeutics, Inc. (DRTX), bought 3,000 shares at $13.72 ($41K) on 2014-08-12, disclosed to the SEC on 2014-08-13.
Open-market purchase of $41k DRTX by Chief Commercial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| XERS | BUY | 2023-11-17 | $101K | — | Filing → |
| XERS | BUY | 2021-11-12 | $210K | — | Filing → |
| XERS | BUY | 2020-05-14 | $78K | — | Filing → |